Cargando…

A case of metastatic renal cell carcinoma treated effectively by gemcitabine and sunitinib

A 60-year-old man with renal cell carcinoma developed lung metastases after treatment with left radical nephrectomy (pT3bN0M0, clear cell renal carcinoma, Fuhrman G3 >2). The patient received treatment with gemcitabine and interferon-α and achieved complete response after seven cycles of therapy....

Descripción completa

Detalles Bibliográficos
Autores principales:	Morizane, Shuichi, Iwamoto, Hideto, Yao, Akihisa, Isoyama, Tadahiro, Sejima, Takehiro, Takenaka, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Urological Association 2012
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921806/ https://www.ncbi.nlm.nih.gov/pubmed/24578969 http://dx.doi.org/10.5173/ceju.2012.04.art11

Ejemplares similares

Serum C-reactive protein level is a significant prognostic indicator in patients with advanced urothelial cancer treated with gemcitabine-cisplatin or carboplatin – preliminary results
por: Morizane, Shuichi, et al.
Publicado: (2012)

Low pre–operative levels of serum albumin predict lymph node metastases and ultimately correlate with a biochemical recurrence of prostate cancer in radical prostatectomy patients
por: Sejima, Takehiro, et al.
Publicado: (2013)

Hydronephrosis after retroperitoneal laparoscopic dismembered Anderson–Hynes pyeloplasty in adult patients with ureteropelvic junction obstruction: A longitudinal analysis
por: Isoyama, Tadahiro, et al.
Publicado: (2014)

The significance of predictable traumatic area by renorrhaphy in the prediction of postoperative ipsilateral renal function
por: Masago, Toshihiko, et al.
Publicado: (2017)

Estimation of mortality and morbidity risk of radical cystectomy using POSSUM and the Portsmouth predictor equation
por: Masago, Toshihiko, et al.
Publicado: (2015)

Lysosome-associated membrane protein 2 (LAMP-2) expression induced by miR-194-5p downregulation contributes to sunitinib resistance in human renal cell carcinoma cells
por: Yumioka, Tetsuya, et al.
Publicado: (2018)

A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine
por: Takayoshi, Kotoe, et al.
Publicado: (2015)

Effective Treatment of Upper Urinary Tract Malignancies Using Laparoscopic Surgery in Three Nonagenarians in Poor General Condition: Are They Too Old for Surgery?
por: Sejima, Takehiro, et al.
Publicado: (2018)

Robot-assisted radical prostatectomy: a case series of the first 100 patients -constitutional introduction and implementation on the basis of comprehensive department of minimal invasive surgery center-
por: Sejima, Takehiro, et al.
Publicado: (2013)

Urothelial Carcinoma Recurrence at an Ileal Orthotopic Neobladder and Unilateral Lower Ureter After Surgery
por: Kawamoto, Bunya, et al.
Publicado: (2016)

Postoperative inguinal hernia after robotic-assisted radical prostatectomy for prostate cancer: evaluation of risk factors and recommendation of a convenient prophylactic procedure
por: Iwamoto, Hideto, et al.
Publicado: (2019)

Site-dependent and interindividual variations in Denonvilliers’ fascia: a histological study using donated elderly male cadavers
por: Muraoka, Kuniyasu, et al.
Publicado: (2015)

Site-dependent differences in the composite fibers of male pelvic plexus branches: an immunohistochemical analysis of donated elderly cadavers
por: Muraoka, Kuniyasu, et al.
Publicado: (2018)

The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib
por: Frees, Sebastian, et al.
Publicado: (2018)

Splice variants of lysosome-associated membrane proteins 2A and 2B are involved in sunitinib resistance in human renal cell carcinoma cells
por: Nishikawa, Ryoma, et al.
Publicado: (2020)

Spontaneous regression of metastatic renal cell carcinoma after cytoreductive nephrectomy: A case report
por: Muraoka, Kuniyasu, et al.
Publicado: (2020)

Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib
por: Billemont, B, et al.
Publicado: (2008)

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
por: Gu, Cheng-Yuan, et al.
Publicado: (2021)

Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib
por: Fiala, Ondřej, et al.
Publicado: (2021)

The rare urological entity of ureterosciatic hernia: A case report of successful treatment after repeated recurrence
por: Hoshino, Takahiro, et al.
Publicado: (2023)

Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib
por: Mohammad, H., et al.
Publicado: (2021)

Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
por: Rini, Brian I., et al.
Publicado: (2011)

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib
por: Beuselinck, B, et al.
Publicado: (2013)

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
por: Motzer, R J, et al.
Publicado: (2013)

Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
por: Keizman, Daniel, et al.
Publicado: (2016)

Acute Acalculous Cholecystitis in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2014)

Metastatic collecting duct carcinoma of the kidney treated with sunitinib
por: Tazi, El Mehdi, et al.
Publicado: (2011)

Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma
por: Iyer, Ridhima, et al.
Publicado: (2017)

Complete remission of metastatic renal cell carcinoma to the bone with sunitinib
por: Yoshimura, Akihiro, et al.
Publicado: (2020)

Retraction: metastatic collecting duct carcinoma of the kidney treated with Sunitinib
por: Tazi, El Mehdi, et al.
Publicado: (2011)

Influence of multinerve‐sparing, robot‐assisted radical prostatectomy on the recovery of erection in Japanese patients
por: Yumioka, Tetsuya, et al.
Publicado: (2017)

Complete response to chemotherapy in Burkitt's Lymphoma of the Bladder: A case report
por: Shimizu, Ryutaro, et al.
Publicado: (2020)

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
por: Hutson, T E, et al.
Publicado: (2014)

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma
por: Gilabert, M, et al.
Publicado: (2013)

Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
por: Yildiz, Ibrahim, et al.
Publicado: (2014)

Clinical significance of sunitinib‐associated macrocytosis in metastatic renal cell carcinoma
por: Bourlon, Maria T., et al.
Publicado: (2016)

Erythema multiforme major induced by sunitinib for metastatic renal cell carcinoma
por: Watanabe, Daisuke, et al.
Publicado: (2019)

Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients
por: Numakura, Kazuyuki, et al.
Publicado: (2018)

Treatment of Ureterosciatic Hernia with a Ureteral Stent
por: Yanagi, Koji, et al.
Publicado: (2015)

Intravesical prostatic protrusion may affect early postoperative continence undergoing robot-assisted radical prostatectomy
por: Hikita, Katsuya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_art022i9n3apssm59stlm1v2gf